Pharma News Intelligence November 29, 2023
Veronica Salib

Among almost 30 other proposed plans, the Biden administration announced its intention to strengthen the pharmaceutical supply chain through the DPA.

On Monday, November 27, 2023, the White House released a fact sheet from the Biden administration outlining plans to strengthen domestic supply chains, reduce consumer costs, and secure key supply chain sectors. Amidst the many other supply chains mentioned, the administration announced its plans to bolster the pharmaceutical supply chain and minimize the number of national drug shortages.

One of the significant actions marked by the release of this fact sheet is the first meeting of the White House Council on Supply Chain Resilience, intended to support long-term, government-wide tools to stabilize supply chains. Alongside multiple other federal organizations,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Supply Chain, Technology
Preserving Biological Order: Why Supply Chain Disruptions Are Patient Safety Crises
Why supply chain ROI is shifting from price to prevention
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
HHS outlines plan to bolster the US medical supply chain and 3 more updates to know
Seven steps to AI supply chain visibility — before a breach forces the issue

Share Article